Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
Stock Price Prediction
Update at 5:00pm EST
18.499 - 18.61
18.61 - 18.717
17.6 - 17.729
17.729 - 17.853
18.02 - 18.212
18.212 - 18.397
as of: 2019-09-20 4:25:40 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.OMER has closed above bottom band by 29.1%. Bollinger Bands are 45.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to OMER's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.